145 related articles for article (PubMed ID: 22218677)
1. Seroprevalence of human polyomavirus 9 and cross-reactivity to African green monkey-derived lymphotropic polyomavirus.
Trusch F; Klein M; Finsterbusch T; Kühn J; Hofmann J; Ehlers B
J Gen Virol; 2012 Apr; 93(Pt 4):698-705. PubMed ID: 22218677
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence and cross-reactivity of human polyomavirus 9.
Nicol JT; Touzé A; Robinot R; Arnold F; Mazzoni E; Tognon M; Coursaget P
Emerg Infect Dis; 2012 Aug; 18(8):1329-32. PubMed ID: 22840602
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence rates of HPyV6, HPyV7, TSPyV, HPyV9, MWPyV and KIPyV polyomaviruses among the healthy blood donors.
Šroller V; Hamšíková E; Ludvíková V; Musil J; Němečková Š; Saláková M
J Med Virol; 2016 Jul; 88(7):1254-61. PubMed ID: 26630080
[TBL] [Abstract][Full Text] [Related]
4. Structures of B-lymphotropic polyomavirus VP1 in complex with oligosaccharide ligands.
Neu U; Khan ZM; Schuch B; Palma AS; Liu Y; Pawlita M; Feizi T; Stehle T
PLoS Pathog; 2013 Oct; 9(10):e1003714. PubMed ID: 24204265
[TBL] [Abstract][Full Text] [Related]
5. Crystallographic and glycan microarray analysis of human polyomavirus 9 VP1 identifies N-glycolyl neuraminic acid as a receptor candidate.
Khan ZM; Liu Y; Neu U; Gilbert M; Ehlers B; Feizi T; Stehle T
J Virol; 2014 Jun; 88(11):6100-11. PubMed ID: 24648448
[TBL] [Abstract][Full Text] [Related]
6. Seroepidemiology of the newly found trichodysplasia spinulosa-associated polyomavirus.
Chen T; Mattila PS; Jartti T; Ruuskanen O; Söderlund-Venermo M; Hedman K
J Infect Dis; 2011 Nov; 204(10):1523-6. PubMed ID: 21926381
[TBL] [Abstract][Full Text] [Related]
7. Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus.
Nicol JT; Robinot R; Carpentier A; Carandina G; Mazzoni E; Tognon M; Touzé A; Coursaget P
Clin Vaccine Immunol; 2013 Mar; 20(3):363-8. PubMed ID: 23302741
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and stability of antibodies to thirteen polyomaviruses and association with cutaneous squamous cell carcinoma: A population-based study.
Antonsson A; Neale RE; O'Rourke P; Wockner L; Michel A; Pawlita M; Waterboer T; Green AC
J Clin Virol; 2018 Apr; 101():34-37. PubMed ID: 29414185
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of trichodysplasia spinulosa-associated polyomavirus.
van der Meijden E; Kazem S; Burgers MM; Janssens R; Bouwes Bavinck JN; de Melker H; Feltkamp MC
Emerg Infect Dis; 2011 Aug; 17(8):1355-63. PubMed ID: 21801610
[TBL] [Abstract][Full Text] [Related]
10. Development and Evaluation of a Broad Bead-Based Multiplex Immunoassay To Measure IgG Seroreactivity against Human Polyomaviruses.
Kamminga S; van der Meijden E; Wunderink HF; Touzé A; Zaaijer HL; Feltkamp MCW
J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305551
[TBL] [Abstract][Full Text] [Related]
11. Human polyomavirus 9 infection in kidney transplant patients.
van der Meijden E; Wunderink HF; van der Blij-de Brouwer CS; Zaaijer HL; Rotmans JI; Bavinck JN; Feltkamp MC
Emerg Infect Dis; 2014 Jun; 20(6):991-9. PubMed ID: 24866095
[TBL] [Abstract][Full Text] [Related]
12. A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus.
Scuda N; Hofmann J; Calvignac-Spencer S; Ruprecht K; Liman P; Kühn J; Hengel H; Ehlers B
J Virol; 2011 May; 85(9):4586-90. PubMed ID: 21307194
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of trichodysplasia spinulosa-associated polyomavirus in Japan.
Fukumoto H; Li TC; Kataoka M; Hasegawa H; Wakita T; Saeki H; Suzuki T; Katano H
J Clin Virol; 2015 Apr; 65():76-82. PubMed ID: 25766994
[TBL] [Abstract][Full Text] [Related]
14. Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin.
van der Meijden E; Bialasiewicz S; Rockett RJ; Tozer SJ; Sloots TP; Feltkamp MC
PLoS One; 2013; 8(11):e81078. PubMed ID: 24278381
[TBL] [Abstract][Full Text] [Related]
15. Seroepidemiology of human polyomaviruses.
Kean JM; Rao S; Wang M; Garcea RL
PLoS Pathog; 2009 Mar; 5(3):e1000363. PubMed ID: 19325891
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of human Malawi polyomavirus.
Nicol JT; Leblond V; Arnold F; Guerra G; Mazzoni E; Tognon M; Coursaget P; Touzé A
J Clin Microbiol; 2014 Jan; 52(1):321-3. PubMed ID: 24172149
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiology of the human polyomaviruses.
Stolt A; Sasnauskas K; Koskela P; Lehtinen M; Dillner J
J Gen Virol; 2003 Jun; 84(Pt 6):1499-1504. PubMed ID: 12771419
[TBL] [Abstract][Full Text] [Related]
18. Serological cross-reactivity between human polyomaviruses.
Moens U; Van Ghelue M; Song X; Ehlers B
Rev Med Virol; 2013 Jul; 23(4):250-64. PubMed ID: 23650080
[TBL] [Abstract][Full Text] [Related]
19. Seroepidemiology of Human Polyomaviruses in a US Population.
Gossai A; Waterboer T; Nelson HH; Michel A; Willhauck-Fleckenstein M; Farzan SF; Hoen AG; Christensen BC; Kelsey KT; Marsit CJ; Pawlita M; Karagas MR
Am J Epidemiol; 2016 Jan; 183(1):61-9. PubMed ID: 26667254
[TBL] [Abstract][Full Text] [Related]
20. Novel human polyomaviruses in pregnancy: higher prevalence of BKPyV, but no WUPyV, KIPyV and HPyV9.
Csoma E; Sápy T; Mészáros B; Gergely L
J Clin Virol; 2012 Nov; 55(3):262-5. PubMed ID: 22902204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
